Live symbol workspace

QDEL market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $17.26

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$16.40

Resistance

$18.12

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$17.26

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%

— 0.0 pts vs previous week

Avg confidence across 6 calls in the last 7 days

What sources say

Bullish 1 article

Reasons to Add QuidelOrtho Stock in Your Portfolio for Now

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

QDEL News Intelligence (2 articles)

AI-curated news influencing QDEL price, sentiment, and trend

Explore All QDEL News with AI Analysis

Economy

3 weeks, 3 days ago

Reasons to Add QuidelOrtho Stock in Your Portfolio for Now

QDEL's strong portfolio, cost-saving progress and mixed first-quarter results support growth, though respiratory reliance remains a risk.

Impact on QDEL: Potentially positive price action expected

Analysis of stock market developments showing bullish sentiment. Medium (60%)

View full analysis →

Yahoo Finance 60% confidence

Economy

4 months, 2 weeks ago

Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial …

Impact on QDEL: The escalating U.S.-Iran conflict and associated policy deadlines are causing a risk-off …

Shares of Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell are declining due to escalating U.S.-Iran … High (80%)

View full analysis →

Yahoo Finance 80% confidence